Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Gynecologic 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Sarcoma 1Rectal Neoplasms 1Pancreatic Neoplasms 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Fallopian Tube Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Bile Duct Neoplasms 1Appendiceal Neoplasms 1

Interventions

Ifosfamide 8Doxorubicin 8Blood Specimen Collection 8Radiosurgery 7Proton Therapy 5Surveys and Questionnaires 4Surgical Procedures, Operative 4Standard of Care 4Radiotherapy 4Magnetic Resonance Spectroscopy 4X-Rays 3Vincristine 3Radiation Dose Hypofractionation 3Palliative Care 3Methods 3Mesna 3pegfilgrastim 2pazopanib 2dexamethasone acetate 2Trastuzumab 2Transurethral Resection of Bladder 2Restraint, Physical 2Radiotherapy, Intensity-Modulated 2Protons 2Practice Guidelines as Topic 2Neoadjuvant Therapy 2Methotrexate 2Melphalan 2Heavy Ion Radiotherapy 2Gene Expression Profiling 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Sarcoma × motexafin lutetium × Clear all
NCT00087191 2013-01-16

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase NA Terminated
30 enrolled
GastrointestinalGynecologicSarcomaThoracic

Carcinoma, Ovarian Epithelial, Appendiceal Neoplasms, Bile Duct Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Fallopian Tube Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Rectal Neoplasms, Sarcoma, Stomach Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡